hESC-derived Olig2+ progenitors generate a subtype of astroglia with protective effects against ischaemic brain injury

Nature Communications

Volumn 4, Issue , 2013, Pages

  Jiang, Peng ^a,b   Chen, Chen ^a,b   Wang, Ruimin ^c   Chechneva, Olga V ^a,b   Chung, Seung Hyuk ^a,b   Rao, Mahendra S ^d   Pleasure, David E ^a,b   Liu, Ying ^e   Zhang, Quanguang ^c   Deng, Wenbin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; GREEN FLUORESCENT PROTEIN; NERVE PROTEIN; OLIG2 PROTEIN, HUMAN;

BRAIN; CYTOLOGY; DISEASE TREATMENT; GENE EXPRESSION; HETEROGENEITY; HOMINID; INJURY; NERVOUS SYSTEM DISORDER;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN INJURY; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL THERAPY; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROGLIA; MOUSE; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; RAT; THERAPY EFFECT; ANIMAL; CELL CULTURE; CELL LINEAGE; CYTOLOGY; GENETICS; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; METABOLISM; PATCH CLAMP TECHNIQUE; PATHOLOGY; REPORTER GENE; SPRAGUE DAWLEY RAT; STEREOTACTIC PROCEDURE; TRANSPLANTATION; XENOGRAFT;

ANIMALS; ASTROCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; STEREOTAXIC TECHNIQUES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84893156687     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3196     Document Type: Article

References (54)

1. Barres, B. A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60, 430-440 (2008).
2. Krencik, R., Weick, J. P., Liu, Y., Zhang, Z. J. & Zhang, S. C. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat. Biotechnol. 29, 528-534 (2011).
3. Emdad, L., D'Souza, S. L., Kothari, H. P., Qadeer, Z. A. & Germano, I. M. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev. 21, 404-410 (2011).
4. Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S. & De Simone, G. et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, e46-e215 (2010).
5. Smith, G. M. & Silver, J. Transplantation of immature and mature astrocytes and their effect on scar formation in the lesioned central nervous system. Prog. Brain Res. 78, 353-361 (1988).
6. Smith, G. M. & Miller, R. H. Immature type-1 astrocytes suppress glial scar formation, are motile and interact with blood vessels. Brain Res. 543, 111-122 (1991).
7. Ouyang, Y. B., Voloboueva, L. A., Xu, L. J. & Giffard, R. G. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J. Neurosci. 27, 4253-4260 (2007).
8. Lepore, A. C., Rauck, B., Dejea, C., Pardo, A. C., Rao, M. S. & Rothstein, J. D. et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 11, 1294-1301 (2008).
9. Davies, S. J., Shih, C. H., Noble, M., Mayer-Proschel, M., Davies, J. E. & Proschel, C. Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS One 6, e17328 (2011).
10. Oki, K. et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 30, 1120-1133 (2012).
11. Emsley, J. G. & Macklis, J. D. Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS. Neuron Glia Biol. 2, 175-186 (2006).
12. Bachoo, R. M. et al. Molecular diversity of astrocytes with implications for neurological disorders. Proc. Natl Acad. Sci. U S A 101, 8384-8389 (2004).
13. Bordey, A. & Sontheimer, H. Ion channel expression by astrocytes in situ: comparison of different CNS regions. Glia 30, 27-38 (2000).
14. Blomstrand, F., Aberg, N. D., Eriksson, P. S., Hansson, E. & Ronnback, L. Extent of intercellular calcium wave propagation is related to gap junction permeability and level of connexin-43 expression in astrocytes in primary cultures from four brain regions. Neuroscience 92, 255-265 (1999).
15. Davies, J. E. et al. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J. Biol. 7, 24 (2008).
16. Ligon, K. L., Fancy, S. P., Franklin, R. J. & Rowitch, D. H. Olig gene function in CNS development and disease. Glia 54, 1-10 (2006).
17. Furusho, M. et al. Involvement of the Olig2 transcription factor in cholinergic neuron development of the basal forebrain. Dev. Biol. 293, 348-357 (2006).
18. Malatesta, P. et al. Neuronal or glial progeny: regional differences in radial glia fate. Neuron 37, 751-764 (2003).
19. Setoguchi, T. & Kondo, T. Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor-induced astrocyte differentiation. J. Cell Biol. 166, 963-968 (2004).
20. Marshall, C. A., Novitch, B. G. & Goldman, J. E. Olig2 directs astrocyte and oligodendrocyte formation in postnatal subventricular zone cells. J. Neurosci. 25, 7289-7298 (2005).
21. Masahira, N. et al. Olig2-positive progenitors in the embryonic spinal cord give rise not only to motoneurons and oligodendrocytes, but also to a subset of astrocytes and ependymal cells. Dev. Biol. 293, 358-369 (2006).
22. Tsai, H. H. et al. Regional astrocyte allocation regulates CNS synaptogenesis and repair. Science 337, 358-362 (2012).
23. Guo, F. et al. Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis. J. Neurosci. 31, 11914-11928 (2011).
24. Cai, J. et al. A crucial role for Olig2 in white matter astrocyte development. Development 134, 1887-1899 (2007).
25. Xue, H. et al. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells 27, 1836-1846 (2009).
26. Liu, Y., Jiang, P. & Deng, W. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation. Nat. Protoc. 6, 640-655 (2011).
27. Gross, R. E. et al. Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17, 595-606 (1996).
28. Liu, Y. et al. CD44 expression identifies astrocyte-restricted precursor cells. Dev. Biol. 276, 31-46 (2004).
29. Dahl, D., Rueger, D. C., Bignami, A., Weber, K. & Osborn, M. Vimentin, the 57 000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. Eur. J. Cell Biol. 24, 191-196 (1981).
30. Gupta, K. et al. Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ. 19, 779-787 (2011).
31. Shaltouki, A., Peng, J., Liu, Q., Rao, M. S. & Zeng, X. Efficient generation of astrocytes from human pluripotent stem cells in defined conditions. Stem Cells 31, 941-952 (2013).
32. Black, J. A., Newcombe, J. & Waxman, S. G. Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5. Brain 133, 835-846 (2010).
33. Pfrieger, F. W. Role of glial cells in the formation and maintenance of synapses. Brain Res. Rev. 63, 39-46 (2010).
34. Mauch, D. H. et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357 (2001).
35. Christopherson, K. S. et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421-433 (2005).
36. Allen, N. J. et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486, 410-414 (2012).
37. Bell, K. F. et al. Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc. Natl Acad. Sci. USA 108 (E1-2) E3-E4 (2010).
38. Haskew-Layton, R. E. et al. Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc. Natl Acad. Sci. USA 107, 17385-17390 (2010).
39. Nomura, T. et al. Infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136, 161-169 (2005).
40. Zhang, Y. & Pardridge, W. M. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res. 1111, 227-229 (2006).
41. Kitagawa, K. et al. The synapsin I brain distribution in ischemia. Neuroscience 46, 287-299 (1992).
42. Stroemer, R. P., Kent, T. A. & Hulsebosch, C. E. Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 26, 2135-2144 (1995).
43. Oberheim, N. A. et al. Uniquely hominid features of adult human astrocytes. J. Neurosci. 29, 3276-3287 (2009).
44. Hu, B. Y., Du, Z. W. & Zhang, S. C. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat. Protoc. 4, 1614-1622 (2009).
45. Selvaraj, V., Jiang, P., Chechneva, O., Lo, U. G. & Deng, W. Differentiating human stem cells into neurons and glial cells for neural repair. Front. Biosci. 17, 65-89 (2011).
46. Choi, D. W. Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res. 100, 47-51 (1994).
47. Chan, P. H. Role of oxidants in ischemic brain damage. Stroke 27, 1124-1129 (1996).
48. Lo, F. S., Zhao, S. & Erzurumlu, R. S. Astrocytes promote peripheral nerve injury-induced reactive synaptogenesis in the neonatal CNS. J. Neurophysiol. 106, 2876-2887 (2011).
49. Plane, J. M., Grossenbacher, S. K. & Deng, W. PARP-1 deletion promotes subventricular zone neural stem cells toward a glial fate. J. Neurosci. Res. 90, 1489-1506 (2012).
50. West, M. J., Slomianka, L. & Gundersen, H. J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231, 482-497 (1991).
51. Jiang, P. et al. Electrophysiological properties of human induced pluripotent stem cells. Am. J. Physiol. Cell Physiol. 298, C486-C495 (2010).
52. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001).
53. Zhang, Q. G. et al. C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection. Proc. Natl Acad. Sci. USA 108, E617-E624 (2011).
54. Morris, R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60 (1984).